Dr. Vijay Krishna is an Associate Staff in Biomedical Engineering at Cleveland Clinic Research and an inventor with 25+ patents and applications. His lab develops functional nanotechnologies for disease prevention and therapy, emphasizing safety-by-design and scalable translation. He is advancing Fullerase, an inorganic enzyme-mimicking nanocatalyst platform to restore or augment biochemical function without protein therapeutics. The team combines materials engineering, spectroscopy, and mechanistic testing to build durable catalysts with tunable activity. His goal is to translate Fullerase into scalable therapeutic and diagnostics products via partnerships, early validation, and a clear commercialization path.